Bis[bis(3,5-dimethylpyrazol-1-yl)(dimethylamino)methane]copper(II) perchlorate−bis(dichloromethane), Cu(II)( 1 ) 2 (ClO 4 ) 2 ·2CH 2 Cl 2, 2, is the unanticipated product of the reaction of tris(3,5-dimethylpyrazol-1-yl)methylsilane, 3, with Cu(II)(DMF) 4 (ClO 4 ) 2 . In the title complex, the Cu(II)( 1 ) 2 cations exhibit a tetragonal Cu(II)N 6 geometry arising from coordination of four pyrazole N atoms and two tertiary amine N atoms from two bis(3,5-dimethylpyrazol-1-yl)(dimethylamino)methane ligands, 1 . The tridentate (N) 3 ligands 1 coordinate copper facially with one Cu−N (pyrazole) axial [Cu−N, 2.407(4) Å] and the second equatorial [Cu−N, 1.995(4) Å]; the cations exhibit crystallographic 2-fold symmetry that relates one ligand to the other. Cu(II)( 1 ) 2 (ClO 4 ) 2 ·2CH 2 Cl 2, CuC 28 H 46 Cl 6 N 10 O 8 ·2CH 2 Cl 2, crystallizes in the monoclinic space group C 2/ c, with a = 26.278(5) Å, b = 8.835(2) Å, c = 20.655(4) Å, β = 120.73(3)°, Z = 4, and R F ( R wF 2 ) = 0.049 (0.122) for 1979 observed reflections with I > 2σ( I ). Crystals of 2 are stable in dry air but hydrolyze readily to yield dimethylformamide and 3,5-dimethylpyrazole. A mechanism is proposed for the formation of complex 2 by silane-promoted aminalization (an aminal is the diaza analogue of an acetal) of dimethylformamide.
No takes yet. Share an insight, caveat, or question.
Stibrany et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: